Mirum Pharmaceuticals, Inc.

NASDAQ (USD): Mirum Pharmaceuticals, Inc. (MIRM)

Last Price

38.85

Today's Change

+0.15 (0.38%)

Day's Change

38.31 - 39.44

Trading Volume

188,564

Overview

Market Cap

1 Billion

Shares Outstanding

47 Million

Avg Volume

579,623

Avg Price (50 Days)

40.71

Avg Price (200 Days)

31.23

PE Ratio

-16.82

EPS

-2.31

Earnings Announcement

31-Oct-2024

Previous Close

38.70

Open

38.94

Day's Range

38.3147 - 39.44

Year Range

23.14 - 45.23

Trading Volume

188,564

Price Change Highlight

1 Day Change

0.39%

5 Day Change

-1.55%

1 Month Change

-12.20%

3 Month Change

17.34%

6 Month Change

54.66%

Ytd Change

29.41%

1 Year Change

26.14%

3 Year Change

112.30%

5 Year Change

300.93%

10 Year Change

194.10%

Max Change

194.10%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment